Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1626
This examiner grants 75% of resolved cases
Laura Lynne Stockton is a patent examiner in Tech Center 1600 and Art Unit 1626. She has a substantial record of 1363 resolved cases. The examiner maintains an allowance rate of 75.2 percent, which indicates that a majority of applications reach issuance. This percentage suggests that the examination process in this unit frequently results in a grant for the applicant.
The median time to allowance is 854 days. This timeframe provides a clear expectation for the duration of the prosecution cycle, showing that successful applications reach issuance within this median period. This efficiency is a key characteristic of the examiner's historical data and is an important consideration for practitioners managing patent portfolios in Tech Center 1600.
The data also shows an interview lift of 33.7 percent. This significant lift indicates that direct communication with the examiner is a very effective tool for increasing the chances of an allowance. The 33.7 percent figure suggests that interviews are a key tactical recommendation for overcoming rejections. These combined metrics define the examination environment for applicants in Art Unit 1626.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18756360 | Nucleoside Prodrugs and Uses Related Thereto | Non-Final OA | Emory University |
| 17642662 | CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF | Final Rejection | President and Fellows of Harvard College |
| 18689148 | ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | Non-Final OA | MERCK SHARP & DOHME LLC |
| 18022470 | ESTER COMPOUND | Non-Final OA | MITSUI CHEMICALS, INC. |
| 18725391 | ANTIMICROBIAL COMPOUNDS AND METHODS | Non-Final OA | The University of Utah Research Foundation |
| 18274867 | NOVEL BENZOTRIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE, AND USE THEREOF | Final Rejection | TXINNO BIOSCIENCE INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy